Yasin Oduk

Chief Executive Officer @Nanomedigene

New Haven, CT, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2019 — Present

Chief Executive Officer @Nanomedigene

View department →

New Haven, CT, US

Founded and lead NanomediGene LLC, focusing on innovative drug-delivery platforms for cardiovascular, renal, and oncology care. • Oversee R&D strategy and translational collaborations, guiding projects from concept to preclinical validation. • Combine expertise in nanomedicine and biomaterials to enhance therapeutic efficacy while reducing toxicity.

EDUCATION

2009 — 2012

University of Alabama at Birmingham

Master’s Degree

2012 — 2015

University of Alabama at Birmingham

Doctor of Philosophy - PhD

ABOUT YASIN ODUK

Scientist–Founder building targeted drug delivery platforms that move the needle in challenging indications.As CEO of NanomediGene with over six years of leadership experience, I focus on driving innovation in the field of nanomedicine and targeted drug delivery. My work emphasizes developing cutting-edge biomedical solutions that address critical challenges in oncology and cardiovascular health. With expertise in nanoparticles, targeted drug delivery systems, and biomaterials, I lead initiatives that leverage advanced technologies to create impactful therapeutic solutions. My goal is to foster strategic partnerships and collaborations to advance medical science and improve patient outcomes globally.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Yasin Oduk — Chief Executive Officer at Nanomedigene in New Haven, CT, US | Unifers